Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

36.07 +0.55 (+1.54%)
Streaming Delayed Price Updated: 1:56 PM EST, Feb 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
News headline image
Joblessness Surprise ↗
Despite higher production for the Emirates the price of oil rose sharply today. More output should cut prices. 
Via Talk Markets
News headline image
Panic Attack ↗
The H1 rise in US markets was based on hope for an end to lockdowns. 
Via Talk Markets
News headline image
Understanding Teva Pharmaceutical Indus's Unusual Options Activity ↗
Shares of Teva Pharmaceutical Indus (NYSE:TEVA) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved up to $8.98. Sentiment... 
Via Benzinga
News headline image
Teva Announces Changes to Executive Management Team
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
“Claw-Back” day ↗
The rally was just as irrational as the selloff. 
Via Talk Markets
News headline image
Drug Stocks McKesson, AmerisourceBergen Pop On Reports Of $26 Billion Settlement In Opioid Fight ↗
Drug stocks popped Tuesday on reports they could pay $21 billion to settle claims they helped fuel the nation's opioid epidemic. 
Via Investor's Business Daily
Topics Lawsuit
News headline image
Delta Defeats Bulls ↗
Stocks tended to crash without rhyme or reason. 
Via Talk Markets
News headline image
Unusual Options Activity Insight: Teva Pharmaceutical Indus ↗
On Monday, shares of Teva Pharmaceutical Indus (NYSE:TEVA) saw unusual options activity. After the option alert, the stock price moved down to $8.38. Sentiment: BULLISH Option... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
Stocks That Hit 52-Week Lows On Monday Monday morning, 285 companies reached new 52-week lows. Noteworthy Points: The largest company by market cap to set a new 52-week... 
Via Benzinga
News headline image
Weak Week ↗
Friday tried a recovery because retail sales data for June were strong, particularly in dining out, although in the end, the weak tech side cut the optimism. 
Via Talk Markets
News headline image
Selloff Round 3 ↗
Stocks fell across the board in foreign countries, except for Britain which was upbeat. 
Via Talk Markets
News headline image
Yellow Card ↗
The price of oil fell about 1% today. 
Via Talk Markets
News headline image
Analyzing Teva Pharmaceutical Indus's Unusual Options Activity ↗
On Monday, shares of Teva Pharmaceutical Indus (NYSE:TEVA) saw unusual options activity. After the option alert, the stock price moved up to $9.31. Sentiment: BEARISH Option... 
Via Benzinga
News headline image
Recovery Friday ↗
The big winners this week were Financials. 
Via Talk Markets
News headline image
Biohaven Stock Hits Record High As Migraine Drug Trounces Quarterly Forecasts ↗
Biohaven crushed Wall Street's expectations for second-quarter sales of migraine drug Nurtec on Tuesday, leading BHVN stock to pop. 
Via Investor's Business Daily
News headline image
Sell Sell Sell ↗
Today the inevitable reversal of wild gains overtook Wall Street, echoing what occurred in major foreign markets Monday. 
Via Talk Markets
News headline image
People Needed ↗
If qualified people are not looking for work, they will have to be lured to do so with higher wages. 
Via Talk Markets
News headline image
Teva Recalls One Batch Of Topotecan After Complaint Of Glass Particulate In Vial ↗
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is recalling one lot of its cancer drug topotecan injection after a pharmacy complaint flagged the presence of a single glass... 
Via Benzinga
Topics Product Recall
News headline image
Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 28, 2021
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
End Of June ↗
Canadian Solar fell 4.6% on fears of plans for a China IPO where its panels are made. 
Via Talk Markets
Topics Initial Public Offering
News headline image
Lots Of Deal News ↗
Today Didi, a Chinese ride-hailing stock is doing its IPO reportedly at above the level projected in its application. 
Via Talk Markets
Topics Initial Public Offering
News headline image
New York Takes Drugmakers, Drug Retailers To Legal Trial Over Opioid ↗
Teva Pharmaceutical Industries Ltd (NYSE: TEVA), Endo International Plc (NASDAQ: ENDP), and AbbVie Inc's (NYSE: ABBV) Allergan misleadingly... 
Via Benzinga
News headline image
JNJ's $260M Settlement Could Serve As Global Opioid Deal Template: Analyst ↗
Over the weekend, Johnson & Johnson (NYSE:JNJ) reached a ... 
Via Benzinga
News headline image
Teva and Bioeq Announce Commercial Partnership for Biosimilar
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
Johnson & Johnson Reaches $230M Settlement With New York To End Sale Of Opioids Nationwide ↗
The company has said that it has not marketed opioids in the U.S. since 2015 and discontinued the business in 2020. JNJ did not admit liability in settling with New York State, Nassau, and Suffolk... 
Via Talk Markets
News headline image
Johnson & Johnson Reaches $230M Settlement With New York State To End Sale Of Opioids Nationwide ↗
On Saturday, Johnson & Johnson (NYSE: JNJ) said it would end the manufacture and sale of opioids nationwide in a $230 million settlement with the New York state,... 
Via Benzinga
News headline image
Summer Friday ↗
The stock market tried for another record after yesterday's late blowout over the infrastructure deal. 
Via Talk Markets
News headline image
Teva Announces Ministry of Health, Labour and Welfare Approves AJOVY® (fremanezumab) Injection in Japan for the Preventive Treatment of Migraine in Adults
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
Reconsidered Boom ↗
The US markets tried to repeat the big rise from yesterday, and appears to have succeeded. 
Via Talk Markets
News headline image
Teva Announces Its Launch of the First Generic PERFOROMIST®, Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, Used to Treat Chronic Obstructive Pulmonary Disease (COPD), in the United States
From Teva Pharmaceutical Industries Limited
Via Business Wire
< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.